Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 6 studies | 82% ± 20% | |
endothelial cell | 3 studies | 39% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 4 studies | 45% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 172018.82 | 226 / 226 | 99% | 1462.41 | 400 / 406 |
prostate | 100% | 250.64 | 244 / 245 | 90% | 3.00 | 453 / 502 |
breast | 98% | 558.89 | 452 / 459 | 87% | 26.32 | 976 / 1118 |
pancreas | 96% | 295.80 | 315 / 328 | 42% | 1.02 | 74 / 178 |
adrenal gland | 95% | 68.58 | 244 / 258 | 33% | 1.13 | 76 / 230 |
lung | 99% | 124.40 | 572 / 578 | 25% | 1.06 | 291 / 1155 |
uterus | 100% | 125.89 | 170 / 170 | 22% | 0.58 | 99 / 459 |
brain | 85% | 101.25 | 2255 / 2642 | 35% | 0.67 | 248 / 705 |
intestine | 99% | 117.82 | 953 / 966 | 21% | 6.18 | 113 / 527 |
kidney | 92% | 66.91 | 82 / 89 | 23% | 1.11 | 207 / 901 |
skin | 100% | 142.44 | 1805 / 1809 | 13% | 0.32 | 60 / 472 |
stomach | 95% | 71.48 | 341 / 359 | 17% | 0.44 | 48 / 286 |
bladder | 95% | 109.05 | 20 / 21 | 16% | 0.37 | 82 / 504 |
ovary | 99% | 151.74 | 178 / 180 | 12% | 0.20 | 52 / 430 |
thymus | 99% | 102.94 | 644 / 653 | 8% | 0.13 | 49 / 605 |
esophagus | 89% | 74.78 | 1289 / 1445 | 12% | 1.25 | 22 / 183 |
blood vessel | 99% | 120.88 | 1323 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 399.10 | 238 / 241 | 0% | 0 | 0 / 0 |
adipose | 96% | 113.25 | 1158 / 1204 | 0% | 0 | 0 / 0 |
heart | 69% | 43.89 | 593 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 37% | 33.03 | 346 / 929 | 0% | 0 | 0 / 0 |
muscle | 33% | 14.18 | 268 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.12 | 3 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 3% | 0.04 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_0060335 | Biological process | positive regulation of type II interferon-mediated signaling pathway |
GO_0060333 | Biological process | type II interferon-mediated signaling pathway |
GO_0020027 | Biological process | hemoglobin metabolic process |
GO_0042168 | Biological process | heme metabolic process |
GO_0002639 | Biological process | positive regulation of immunoglobulin production |
GO_0006879 | Biological process | intracellular iron ion homeostasis |
GO_0002925 | Biological process | positive regulation of humoral immune response mediated by circulating immunoglobulin |
GO_0015886 | Biological process | heme transport |
GO_0005615 | Cellular component | extracellular space |
GO_0071682 | Cellular component | endocytic vesicle lumen |
GO_0072562 | Cellular component | blood microparticle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0015232 | Molecular function | heme transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | HPX |
Protein name | Hemopexin (Beta-1B-glycoprotein) |
Synonyms | |
Description | FUNCTION: Binds heme and transports it to the liver for breakdown and iron recovery, after which the free hemopexin returns to the circulation. |
Accessions | P02790 ENST00000265983.8 |